Keishi Ichikawa
Overview
Explore the profile of Keishi Ichikawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Punnanithinont N, Kambalapalli S, Iskander B, Ichikawa K, Krishnan S, Lakshmanan S, et al.
Curr Atheroscler Rep
. 2024 Dec;
27(1):19.
PMID: 39699771
Purpose Of Review: Inflammation has been commonly known for the past decade as a part of the pathophysiology of atherosclerosis, along with lipid accumulation. However, some patients with optimized lipid-lowering...
2.
Ichikawa K, Lim J, McClelland R, Susarla S, Krishnan S, Benzing T, et al.
Circ Cardiovasc Imaging
. 2024 Sep;
17(9):e016465.
PMID: 39288206
Background: For individuals with a coronary artery calcium (CAC) score of 0, CAC rescans at appropriate timings are recommended, depending on individual risk profiles. Although nonalcoholic fatty liver disease, recently...
3.
Hamidi H, Bagheri M, Benzing T, Krishnan S, Kianoush S, Ichikawa K, et al.
Am Heart J
. 2024 Aug;
278:24-32.
PMID: 39187147
Introduction: Tirzepatide is a novel once-week dual GIP/GLP-1 RA agonist approved for T2DM and its role to reduce cardiovascular events remains to be elucidated. The goal of this trial is...
4.
Krishnan S, Aldana-Bitar J, Golub I, Kianoush S, Benzing T, Ichikawa K, et al.
Prog Cardiovasc Dis
. 2024 Jul;
86:73-74.
PMID: 39029567
No abstract available.
5.
Manubolu V, Lu J, Montano B, Kininger A, Bainiwal J, Verghese D, et al.
Int J Cardiovasc Imaging
. 2024 Jul;
40(9):1951-1959.
PMID: 39008195
Epicardial adipose tissue (EAT) may enhance the risk of coronary artery disease (CAD). We investigated the relationship between EAT density (a maker of local inflammation) and coronary plaque characteristics in...
6.
Javier D, Manubolu V, Norwitz N, Kinninger A, Aldana-Bitar J, Ghanem A, et al.
Coron Artery Dis
. 2024 Jun;
35(7):577-583.
PMID: 38861193
Background: Despite innovations in pharmacotherapy to lower lipoprotein cholesterol and apolipoprotein B, risk factors for atherosclerotic cardiovascular disease (ASCVD), ASCVD persists as the leading global cause of mortality. Elevations in...
7.
Manubolu V, Ichikawa K, Budoff M
Prog Cardiovasc Dis
. 2024 May;
84:51-59.
PMID: 38754532
Coronary computed tomography angiography (CCTA) has emerged as a pivotal tool in the non-invasive evaluation of coronary artery disease (CAD). Recent advancements in imaging techniques, quantitative plaque assessment methods, assessment...
8.
Nishihara T, Miyoshi T, Nakashima M, Miki T, Toda H, Yoshida M, et al.
Cardiovasc Diabetol
. 2024 May;
23(1):167.
PMID: 38730426
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the proposed name change for non-alcoholic fatty liver disease (NAFLD). This study aimed to investigate the association of cardiovascular disease risk with...
9.
Golub I, Benzing T, Kianoush S, Krishnan S, Ichikawa K, Budoff M
Coron Artery Dis
. 2024 Apr;
35(5):440-441.
PMID: 38652086
No abstract available.
10.
Ichikawa K, Wang R, McClelland R, Manubolu V, Susarla S, Lee D, et al.
Heart
. 2024 Apr;
110(14):947-953.
PMID: 38627022
Methods: A total of 2412 participants who underwent both chest CT and ECG-gated cardiac CT at the same period were included in the Multi-Ethnic Study of Atherosclerosis Exam 5. All...